Navigation Links
Ceramide Directs Stem Cells in Embryo

to do,' says Dr. Guanghu Wang, MCG research assistant scientist who shares first authorship.

In 2003, Dr. Bieberich and his colleagues reported ceramide teams up with the protein PAR-4 to eliminate useless cells in developing brains.

Now his team reports that ceramide plays a key role in establishing cell polarity by attracting proteins involved in polarity to the top of the cells then triggering a series of interactions between them.

When researchers inhibited ceramide production, polarity proteins didn’t gather at the top of cells, cells died and primitive ectoderm formation was impaired; all processes worked like a charm when ceramide was restored.

They plan to study what unknown roles ceramide may play in mature cells and if it plays a role in some cells losing their direction and becoming cancerous.

'There are conditions where a lot of cells die by what we call apoptosis and, in these cases, it could be that ceramide is elevated and that causes good cells to die,' says Dr. Bieberich. Ultraviolet radiation, says Mr. Krishnamurthy, is a good example of what may increase ceramide levels.

To study the quantity and location of ceramide, the researchers first developed an antibody that binds to it so it could be seen and counted. Previously, chemical studies have documented its presence but nothing more.

Longstanding collaborator Dr. Brian G. Condie, developmental neurobiologist at the University of Georgia in Athens, and Dr. Jeane Silva, MCG research coordinator, also are study co-authors.

The National Institutes of Health funded the work.

Source-EurekalertPRI
'"/>




Page: 1 2

Related medicine news :

1. Ceramide can target and kill cancer cells
2. Rajasthan Directs Doctors to Prescribe Medicines by Generic Names
3. Thailand Directs Pharma Companies to Declare Production Cost of Drugs
4. Blood Cells Capable of Regenerating Liver
5. White Cells Count Can Predict Heart Attack Death Risk
6. Gene Therapy Destroys Pancreatic Cancer Cells
7. Stem Cells Have Few Mutations
8. Heart may pull Cells from Body to Self-repair
9. Cells critical for asthma development found
10. Vitamin D Wipes out Cancer Cells
11. Bone Marrow Cells Help Heart Attack Patients

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Ceramide Directs Stem Cells Embryo

(Date:11/7/2009)...A. Cook (GA), Louis J. Goodman (TX), Palmer P. Jon...GO, Nov. 7 The American...dical society executive leaders with achievement a...d ideals of the medical profession. The awards wer... meeting in Houston. ,, (Logo: http://www.ne...
(Date:11/7/2009)...a responsibility to vigorously oppose abortion in ... WASHINGTON, Nov. 7 ...d the following statement on the news that Cardina...s Affordable Health Care for America Act (H.R. 396...o for abortion is voted upon. ,, "Our Catholic...
(Date:11/7/2009)...Society of America (PRSA) will bestow the distingu...r vice president of Brand Strategy, Communications...ny at PRSA,s 2009 International Conference in San ...of Fellows is one of the profession,s highest indi...llow PRSA, and 2009 chair of the College of Fellow...
(Date:11/7/2009)...economic climate, many Americans are monitoring th...y on what that they consider to be absolutely esse...elieves that it’s very important for overwei...o improve their health, and he is trying to make w...tough economy by offering reasonable prices and mu...
(Date:11/6/2009)...Georgia graduate was featured in a local news show.... The special report focused on the growing proble...rt Andrew shared his near death experience and his...iption drug abuse. ,, "I woke up, blinked once and...er on top of me giving me CPR. I saw tears streami...
Breaking Medicine News(10 mins):Health News:AMA Honors Medical Society Executives 2Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 3Health News:Dallas Bariatric Surgeon Offers Multiple Options for Patients Considering Weight Loss Surgery in a Rough Economy 2Health News:Dallas Bariatric Surgeon Offers Multiple Options for Patients Considering Weight Loss Surgery in a Rough Economy 3Health News:Narconon Drug Rehab of Georgia Graduate Featured on Local News 2
...Researchers in the North Central Cancer Treatment ... intravenous calcium and magnesium before and afte...ent of advanced colon cancer experience a signific...omplete a full course of treatment. The findings ...
...creased use of MRI before surgeries, researchers r... -- After years of declining rates, the number of ... is on the rise again, the Mayo Clinic now reports...sent their findings May 31 at the American Society...
...lif., May 16 Anesiva,Inc. (Nasdaq: ANSV ) today ...hief executive officer, will present at the Citi I... New York City on May 22, 2008 at 9:30 a.m.,EDT., ...lease connect to Anesiva,s website several minutes...
...16 Jazz,Pharmaceuticals, Inc. (Nasdaq: JAZZ ) an...resident, will provide a corporate presentation at...ll speak at the UBS Global Specialty and Generic,P... the FBR Capital,Markets Spring Investor Conferenc...
...d ABT-869 to be Promising in Targeting Cancer Cell... ABBOTT PARK, Ill., May 15 Abbott scientists,will...al investigative,compounds in the company,s oncolo...-263, a Bcl-2 family protein,antagonist, and ABT-8...
...-control audit of community hospitals associated w...ts that a partnership between a major academic can... created, and community hospitals, where most care...mprehensive Cancer Center in Philadelphia, first e...
Other Medicine News:Health News:Study shows that administering calcium and magnesium effectively reduces neurological sensitivity 2Health News:Mastectomies on the Increase 2Health News:Mastectomies on the Increase 3Health News:Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting 2Health News:Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting 3Health News:Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting 4Health News:Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting 5Health News:Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting 6Health News:Partnership of academic centers and community hospitals effective model for disseminating advances 2Health News:Partnership of academic centers and community hospitals effective model for disseminating advances 3
(Date:11/6/2009)...ire/ -- Kaiser Foundation Health Plan, Inc., Kaise...aries reported today a combined total operating re...mber 30, 2009, compared to $10.2 billion in the th...third quarter was $336 million, compared to $307 m...operating income was $233 million in the third qua...
(Date:11/6/2009)...tCall/ -- Caraco Pharmaceutical Laboratories, Ltd....amine ophthalmic solution, 0.5% following a final ...(FDA) for Sun Pharma,s Abbreviated New Drug Applic...olution on the first day following patent expirati...equivalent to Acular® Ophthalmic Solution, 0....
(Date:11/6/2009)...ire-FirstCall/ -- Derma Sciences, Inc. (OTC Bu...care products, announced plans to release its thir...vember 16, 2009. The Company will hold a conferenc...00 am EST. Interested parties should call (866) 78...), with passcode 81416481 to access the call. You ...
Breaking Medicine Technology:Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 2Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 3Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 4Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution 2Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call 2Contour Products Promotes Survey for National Respiratory Care Week Findings Prove Benefits of Contour CPAP Pillow for Sleep Apnea Patients 60156 1Contour Products Promotes Survey for National Respiratory Care Week Findings Prove Benefits of Contour CPAP Pillow for Sleep Apnea Patients 60156 2Contour Products Promotes Survey for National Respiratory Care Week Findings Prove Benefits of Contour CPAP Pillow for Sleep Apnea Patients 60156 3PrepareCo com Introduces New Online Source for Emergency Self Reliant Food 26amp 3B Survival Products 60151 1PrepareCo com Introduces New Online Source for Emergency Self Reliant Food 26amp 3B Survival Products 60151 2TOPAZ Technologies Announces SoBran Inc as New Customer 14612 1TOPAZ Technologies Announces SoBran Inc as New Customer 14612 2TOPAZ Technologies Announces SoBran Inc as New Customer 14612 3
...ICAAC -, BRIDGEWATER, N.J., Sept. 18 Results fro... Phase 3 study showed that 84 percent of,treatment...onal dose of,PREZISTA(TM) (darunavir) 800 mg (two ...ith TRUVADA(R)(1) (emtricitabine and tenofovir dis...ad (<50 copies/mL) at week 48,compared with 78...
...eutics,(Nasdaq: FOLD ) today announced that it pl...T2220 (1-deoxynojirimycin HCl) for Pompe Disease a...nual Meeting on October 23-27,in San Diego, CA. Th...nd,Chief Executive Officer, at the Merrill Lynch G...ence in London, United Kingdom. About Amicus Ther...
Other Medicine Technology:New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy 2New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy 3New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy 4New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy 5New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy 6New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy 7Amicus Therapeutics Announces Plans to Present Phase 1 Data for AT2220 for Pompe Disease 2
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
Medicine Products: